Key points
In fatty liver disease (MASLD/NAFLD, metabolic dysfunction-associated steatotic liver disease), controlled trials exist for three substances — vitamin E, silymarin, and N-acetylcysteine (NAC). The largest proven effect comes from weight loss.
| Ingredient | Amount per serving | How it is useful | What human studies showed |
|---|---|---|---|
| Vitamin E | 800 IU per day, 96 weeks | the only one of the three with a biopsy-confirmed effect on the liver | in the PIVENS RCT in people without diabetes with biopsy-confirmed NASH — the only arm to meet the primary histologic endpoint (PMID 20427778) |
| Silymarin (milk thistle) | 700 mg 3 times a day (2100 mg), 48 weeks | a complex of six major flavonolignans from milk thistle | in a double-blind placebo-controlled RCT in people with NASH without cirrhosis — improved laboratory markers (PMID 28419855) |
| NAC (N-acetylcysteine) | 600 mg twice a day, 3 months | a precursor to glutathione, the liver's key antioxidant | in 30 patients with fatty liver disease, significantly reduced ALT and spleen size compared with vitamin C (PMID 22308119) |
| Weight loss | 7–10% | first-line intervention | histologically regresses NASH — a larger effect than any supplement (Vilar-Gomez 2015, PMID 25865049) |
How each substance helps
Vitamin E
The PIVENS trial (Pioglitazone versus Vitamin E versus Placebo, N Engl J Med 2010;362:1675–1685, PMID 20427778) was a randomized placebo-controlled trial in non-diabetic patients with biopsy-confirmed NASH. Vitamin E at 800 IU/day for 96 weeks was the only arm to meet the prespecified primary histologic endpoint — improvement on a strict liver histology scoring system.
Silymarin (milk thistle)
Silymarin is a complex of six major flavonolignans from milk thistle (Silybum marianum). A randomized double-blind placebo-controlled trial in non-cirrhotic NASH patients (Clin Gastroenterol Hepatol, PMID 28419855) used silymarin 700 mg three times daily (2100 mg/day) for 48 weeks and showed improved laboratory markers.
N-acetylcysteine (NAC)
NAC is a precursor to glutathione, the liver's key antioxidant. A controlled trial (Khoshbaten M, et al., Hepat Mon, PMID 22308119) compared NAC 600 mg twice daily to vitamin C 1000 mg twice daily in 30 patients with fatty liver disease over 3 months. NAC significantly reduced ALT and spleen size compared to vitamin C.
How to take
- Baseline diagnostics: ALT, AST, FIB-4 (see ALT without symptoms: silent liver diseases) — supplements without a baseline fibrosis assessment are not meaningful.
- 7–10% weight loss — first line.
- Vitamin E 800 IU/day — discuss with a physician for confirmed NASH without diabetes, recheck at 3–6 months.
- Silymarin 2100 mg/day (700 mg×3) — an alternative or addition, recheck ALT/AST at 8–12 weeks.
- NAC 600 mg twice daily — for intolerance to other options or as an addition.
- Recheck at 3–6 months — ALT, AST, and FibroScan if available.
Who should see a doctor first
Discuss any nutraceutical plan with your treating physician before starting, especially with diabetes, anticoagulant use, or planned use beyond a few months.
- Vitamin E is not a "just in case" supplement. Long-term high-dose vitamin E (>400 IU/day) has been associated in other populations with a small increase in all-cause mortality and hemorrhagic stroke risk. PIVENS does not support benefit from continuing beyond the studied protocol: the duration is decided with a physician, not self-extended indefinitely.
- ALT persistently above 30 U/L (men) / 19 U/L (women) not explained by alcohol or viral hepatitis.
- Confirmed MASLD/NASH with metabolic risk factors (obesity, diabetes, dyslipidemia) — discuss vitamin E, silymarin, or NAC as part of a comprehensive protocol.
- FIB-4 in the gray zone (1.3–2.67) — referral for FibroScan before choosing supplements.
Bottom line
Controlled data in fatty liver disease exists for three substances: vitamin E 800 IU/day (the strongest evidence base, biopsy-confirmed, in people without diabetes), silymarin 2100 mg/day, and NAC 600 mg twice daily (real RCTs of smaller scale). None replaces 7–10% weight loss — the intervention with the largest proven effect on the liver.
I assess fatty liver disease stage (ALT, AST, FIB-4, FibroScan referral when indicated) and build a protocol based on actual trial evidence, not marketing claims.
Source: Best Liver Supplement for Fatty Liver: What's Actually Proven — Vitamin E, Silymarin, NAC — universum.earth. md_pereligyn — Перелыгин Владимир Игоревич.
